SOME AMR STATISTICS
AMR CAUSES 700,000 DEATHS EVERY YEAR
THERE IS A $20 BILLION INCREASE IN TREATMENT COSTS
THE AMR MARKET IS ESTIMATED TO GROW TO $45 BILLION BY 2019
AMR DEATHS ARE EXPECTED TO RISE TO $10 MILLION BY 2050
THE GLOBAL ECONOMIC COST IS ESTIMATED AT $100 TRILLION
THE AMR MARKET IS ESTIMATED TO GROW TO $57 BILLION BY 2024
Some experts say we are moving back to the pre-antibiotic era. No. This will be a post-antibiotic era. In terms of new replacement antibiotics, the pipeline is virtually dry. A post-antibiotic era means, in effect, an end ot modern medicine as we know it. Things as common as strep throat or a child’s scratched knee could once again kill.
Margaret Chan, Director General WHO
Antimicrobial resistance exists in every country in the world, and is considered to be one of the greatest threats to global health. As of 2016, the antibiotic pipeline consisted of only 37 antibiotics undergoing clinical trials in the US. Most of these 37 antibiotics tackle gram-positive bacterial resistance. Of greater concern is the more virulent and more difficult to treat gram-negative bacterial resistance.
… there are not enough antibiotics in development with the potential to treat the most dangerous pathogens
The Pews Charitable Trust